Elena Moraitis Selected Research

Polyarteritis Nodosa (Periarteritis Nodosa)

1/2021

Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Moraitis Research Topics

Disease

2	Dermatomyositis (Dermatopolymyositis) 01/2018 - 07/2014
1	Rare Diseases (Rare Disease) 01/2023
1	Human Influenza (Influenza) 01/2021
1	COVID-19 01/2021
1	COVID-19 related pediatric multisystem inflammatory disease 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2018
1	Lung Diseases (Lung Disease) 07/2014
1	Arthritis (Polyarthritis) 07/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2014

Drug/Important Bio-Agent (IBA)

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	boldenone undecylenate (Equipoise)IBA 01/2021
1	ofatumumab FDA Link 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	AutoantibodiesIBA 07/2014
1	AntibodiesIBA 07/2014
1	Biomarkers (Surrogate Marker)IBA 07/2014

Therapy/Procedure

1	Remission Induction 01/2021